On the other hand, anti-TNF-α agents have also been used for treating the severe stages of hepatic diseases such as alcoholic hepatitis (AH) [7,8] and non-alcoholic fatty liver disease (NAFLD) [9]. This evidence concerns the gene TNF and alcoholic hepatitis.